Ping-Hung Kuo

7PUBLICATIONS
33CO-AUTHORS
PharmacogenomicsRespiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 26, 2024
Real-World Experience in the Clinical Use of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis in Taiwan: A Post-Marketing Surveillance Study.

Ping-Hung Kuo, Chih-Yen Tu, Chia-Hung Chen

|Mar 12, 2023
Treatment Response Evaluation by Computed Tomography Pulmonary Vasculature Analysis in Patients With Chronic Thromboembolic Pulmonary Hypertension.

Yu-Sen Huang, Zheng-Wei Chen, Wen-Jeng Lee

|May 05, 2022
Comparing Clinical Outcomes of Tiotropium/Olodaterol, Umeclidinium/Vilanterol, and Indacaterol/Glycopyrronium Fixed-Dose Combination Therapy in Patients with Chronic Obstructive Pulmonary Disease in Taiwan: A Multicenter Cohort Study.

Meng-Jer Hsieh, Ning-Hung Chen, Shih-Lung Cheng

|Dec 08, 2021
Switching from omalizumab to mepolizumab therapy improved extra-pulmonary abdominal and cutaneous vasculitis symptoms in a patient with eosinophilic granulomatosis with polyangiitis.

Yu-Hsuan Chen, Ping-Hung Kuo

|Sep 29, 2021
Treatment of electronic cigarette or vaping product use-associated lung injury (EVALI) by corticosteroid and low-dose pirfenidone: Report of a case.

Chia-Hao Wu, Ting-Yu Liao, Yung-Hsuan Chen

|Jul 02, 2021
The Value of Heart Rhythm Complexity in Identifying High-Risk Pulmonary Hypertension Patients.

Shu-Yu Tang, Hsi-Pin Ma, Chi-Sheng Hung

Pageof 2

Frequent Collaborators

1 joint publications

Chia-Tung Wu

1 joint publications

Guo-Hung Li

1 joint publications

Chun-Ta Huang

1 joint publications

Yu-Chieh Cheng